Results 101 to 110 of about 8,454 (202)

Implications of Long-term Proton Pump Inhibitor Use: Promoting Step-Down Therapy for Management of Gastro-esophageal Reflux Disease in the Outpatient Setting [PDF]

, 2015
Per the International Montreal Consensus, gastro-esophageal reflux disease (GERD) is defined as a condition which develops when the reflux of stomach contents causes troublesome symptoms or complications .
Kapadia, Sonam
core   +1 more source

An Exploratory Analysis of Pharmaceutical Price Disparities and Their Implications Among Six Developed Nations [PDF]

In our study of 43 drugs, prescription drug prices in several wealthy nations (Australia, Canada, France, Germany, and the U.K.) were much lower than in the U.S. on average, well below relative per capita GDP. There was relatively little difference among
Calfee, John E., DuPr�, Elizabeth, Villarreal, Mario   +2 more
core   +1 more source

Detection of refractory gastroesophageal reflux disease using the method of daily pH-impedance monitoring: a clinical case

Клинический разбор в общей медицине
Daily pH-impedance monitoring is an effective method for detecting pathologic gastroesophageal refluxes. We would also like to note the value of this method for the diagnosis of refractory gastroesophageal reflux disease (GERD) in the absence of a ...
Tatyana N. Kovalenko, Natalya N. Dekhnich   +1 more
doaj   +1 more source

A Matched Case-Control Study of a Novel Acid-Pump Antagonist and Proton-Pump Inhibitor for the Treatment of Iatrogenic Ulcers Caused by Endoscopic Submucosal Dissection

Gut and Liver, 2010
Background/Aims: Revaprazan, a novel acid-pump antagonist, and proton-pump inhibitors (PPIs) have pH-independent effects on ulcer healing. The addition of a PPI promotes the cell restitution rate as well as vessel regeneration and maturation for ulcer ...
doaj   +1 more source

“INDICACIONES CLÍNICAS DE LOS INHIBIDORES DE LA BOMBA DE PROTONES” (REVISIÓN BIBLIOGRÁFICA) [PDF]

, 2013
Los inhibidores de la bomba de protones (IBP), son los fármacos más potentes y eficaces para el control de la secreción acida gástrica y están dentro de los grupos farmacológicos más prescritos para el tratamiento de enfermedades relacionadas con la ...
Cárdenas González, Tania Alejandra, Jaimes García, Javier   +1 more
core  

Comparison of clinical and pharmacodynamic features of proton pump inhibitors efficacy in gastroesophageal reflux disease

Российский журнал гастроэнтерологии, гепатологии, колопроктологии, 2015
The aim of review. To present literature data on clinical presentation, pharmacodynamic and economic efficiency of standard dozes of proton pump inhibitors (PPI) for gastroesophageal reflux disease (GERD).Summary.
O. A. Storonova, A. S. Trukhmanov
doaj  

Assessment of Food Effect and pH‐Dependent Drug–Drug Interactions of Fruquintinib in Healthy Subjects

Clinical and Translational Science
This two‐sequence, three‐period study (NCT04645940) was designed to evaluate the effect of food and concomitant rabeprazole, a proton pump inhibitor, on the pharmacokinetics (PK) and safety of fruquintinib and its metabolite M11 after a single oral dose ...
Martha Gonzalez, Zhao Yang, William R. Schelman, Xiaofei Zhou, Neeraj Gupta, Caly Chien   +5 more
doaj   +1 more source

Evaluation of Rabeprazole for Gastrointestinal Protection in Acute Coronary Syndrome Patients Treated with Aspirin and Ticagrelor: A Pilot Study. [PDF]

Yonsei Med J
Hyun HK, Lee OH, Roh JW, Heo SJ, Huh CW, Kim Y.   +5 more
europepmc   +1 more source

LOw-Dose RAbeprazole Therapy for Reducing Gastrointestinal Events in Patients with High Bleeding Risk (LORA-HBR): A Prospective, Multicenter, Interventional Study. [PDF]

J Clin Med
Kang DO, Choi CU, Lee JH, Hong YJ, Kim JS, Lee HC, Rhew JY, Cho JH, Kim W.   +8 more
europepmc   +1 more source

Estimates of all cause mortality and cause specific mortality associated with proton pump inhibitors among US veterans: Cohort study [PDF]

, 2019
Al-Aly, Ziyad, Bowe, Benjamin, Li, Tingting, Xian, Hong, Xie, Yan, Yan, Yan   +5 more
core   +1 more source